Abstract: A garment for protecting a line, such as a central line or broviac line, protruding out of a body of a user, the garment having a body strap, and a pocket on an interior side of the body strap to cover and protect the line from the user. The body strap can have a slit through which the line can exit. The garment can have shoulder straps with line traps to further manage the line exiting from the body strap.

Abstract: A catheter assembly may include a catheter adapter. A body of the catheter adapter may include a distal end, a proximal end, and a first lumen extending through the distal end and the proximal end. The catheter adapter may include a side port, which may extend outwardly from the body. The side port may include a second lumen, which may be perpendicular to the first lumen. The catheter assembly may include a catheter extending distally from the distal end of the body. The catheter assembly may include a valve disposed within the first lumen. The valve may include an outer surface that is cylindrical and may seal the first lumen from the second lumen. The catheter assembly may include a divider disposed with the second lumen. The divider may divide the second lumen into a plurality of openings and may increase a burst value of the valve.

Abstract: A catheter assembly (10) comprises a catheter (22), a needle (12) having a sharp distal tip disposed in the catheter (22), a catheter hub (14) housing the catheter (22) and the needle (12), the catheter hub (14) having a collar (34) including a notch (36), a needle shield (20) connected to the catheter hub (14) when the needle (12) is in a first position, and a clip (40) disposed in the needle shield (20) that cooperates with the needle (12), wherein the clip (40) engages the catheter hub (14) in the first position of the needle (12), and the clip (40) disengages the catheter hub (14) via the notch (36) when the needle (12) is retracted to a second position to enclose at least a portion of the needle (12). The clip (40) is mounted in the outer housing (38) of the needle shield (20) via a spade (66) having an outer wall (70) exposed to the outside of the needle shield (20), in order to reduce the overall width of the needle shield (20).

Abstract: A system for inserting a guide catheter into a relatively small vessel may include an expandable introducer configured for inserting into the vessel, expanding to dilate the vessel, and holding the vessel in an open condition. The system may also include a dilator (200) configured for arrangement within the introducer and for dilating the introducer. The expandable introducer may be removable from a catheter extending therethrough. A related method of introducing a catheter into a relatively small vessel may include inserting an introducer with a dilator arranged therein into the relatively small vessel, advancing the dilator within the introducer to split the introducer and dilate the vessel, removing the dilator, inserting a catheter through the dilated introducer and into the vessel, and removing the introducer from the catheter extending therethrough by splitting the introducer and removing laterally from the catheter. An introducer, alone, may also be provided.

Abstract: A guide wire and a medical device are disclosed that have high workability, restrain erroneous puncture by a needle portion for puncture, and assure relative safety. A guide wire for guiding an elongated tubular body or dilator, and which is configured to be inserted in a living body. The guide wire includes a shaft portion, a puncture portion that is fixed to a distal portion of the shaft portion and that forms a hole in living body tissue, and a cover portion that is elastically deformable and that covers the puncture portion, in which when the cover portion is exposed from the elongated tubular body or dilator, the cover portion covers the puncture portion and the cover portion is bent.

Abstract: A method of using a catheter assembly for inserting in a fluid filled space in a body includes providing a main body having a first end portion and a second end portion. The first end portion is positioned within the fluid filled space. The second end portion is adjusted to extend outwardly from the fluid filled space when the first end portion is positioned within the fluid filled space. A catheter tip is connected to the second end portion of the main body. The catheter tip includes a housing having a cavity defined therein and a rotating element positioned within the fluid filled space. The rotating element is rotated within the cavity of the housing to impart movement of the first end portion of the main body within the fluid filled space.

Abstract: Methods for treating hydrocephalus using a shunt, the shunt having one or more CSF intake openings in a distal portion, a valve disposed in a proximal portion of the shunt, and a lumen extending between the one or more CSF intake openings and the valve, the method comprises deploying the shunt in a body of a patient so that the distal portion of the shunt is at least partially disposed within a CP angle cistern, a body of the shunt is at least partially disposed within an IPS of the patient, and the proximal portion of the shunt is at least partially disposed within or proximate to a JV of the patient, wherein, after deployment of the shunt, CSF flows from the CP angle cistern to the JV via the shunt lumen at a flow rate in a range of 5 ml per hour to 15 ml per hour.

Abstract: The present invention provides a medical pressurization control device, comprising an outer tube and a threaded push rod inside the outer tube. A movable caliper comprising two arms, a caliper control member connected to the movable caliper, and an operating member connected to the caliper control member are provided in the outer tube; when the operating member moves from a second position to a first position, the operating member drives the caliper control member to move to a locking position, so as to push the two arms of the movable caliper to hold the threaded push rod for locking the threaded push rod; when the operating member moves from the first position to the second position, the operating member drives the caliper control member to move to a release position, so as to push the two arms of the movable caliper to release the threaded push rod for unlocking the threaded push rod.

Abstract: Described herein is a drug product delivery device and method of delivering a drug on a swab. The drug product delivery device may include an applicator platform housed within a rigid housing. The applicator platform may be in the form of a plunger. The foil drug reservoir cap creates a fluid storage chamber disposed between the foil drug reservoir cap and the plunger. A series of fluidic channels carry fluid from the fluid storage chamber to an applicator. A frangible seal is attached to the plunger between the fluid storage chamber and the applicator. The frangible seal blocks a fluid from moving from the fluid storage chamber into the series of fluidic channels. Actuation of the plunger causes the frangible seal to be ruptured, which causes the fluid to exit the fluid storage chamber and enter into the fluidic channels. The fluidic channels carry the fluid to the applicator.

Abstract: The present disclosure is in the field of gastric resident systems. A device for extended retention in a stomach is provided. The device includes: first, second, and third arms, the second and third arms being pivotally connected to respective ends of the first arm. The device is configured to transform between a compressed configuration and an expanded configuration. The device further includes a biasing member configured to bias the device into the expanded configuration whereby the second and third arms are configured to mechanically engage each other to retain the system in the expanded configuration.

Abstract: To provide a means which makes it possible to reliably administer a sheet-like water-soluble preparation to skins at various sites and supply water from a back side of the sheet-like water-soluble preparation. A nozzle having at least one hole on an end portion having a plane with a size capable of holding a sheet-like water-soluble preparation, and having concave-convex portions on a portion of the plane excluding the hole; and an applicator for a sheet-like water-soluble preparation, which is composed of a liquid container and the nozzle.

Abstract: Embodiments of the present disclosure encompass systems and methods for in-situ/in vivo, bottom-up tissue generation for wound repair, repair of tissue defects, and the like. Embodiments of the systems of the present disclosure include modular scaffolds seeded with cells (modular tissue forming units (MTFUs)) for packing a tissue defect, such that these MTFUs are able to fill the wound bed with cells of one or more needed tissue types supported by the modular scaffolding particles.

Abstract: A high-throughput method, device and system technology is provided capable of unconstrained penetration into virtually any cell type. This technology is completely agnostic to the cargo type or size (DNA, RNA or protein), is ultra-robust due to use of stiff metals, and has a direct path to scalabillity. This technology will serve as an effective method of intracellular delivery. In addition, this device is reusable and capable with working with all cell types, regardless of cell stiffness, and is potentially capable of penetrating into the nucleus of a cell. An intra-cellularly delivery device with an elongated structure with an ultra-sharp tip of less than 10 nanometers enables this technology whereby intracellular access is gained with little to no observable deformation of the cell walls. This dramatically increases the likelihood of cell survival and successful delivery.

Abstract: A needle disk roller apparatus having a built-in pump, includes: a drug container (11) filled with a drug and having a built-in pump assembly (10); and a roller head (14) being able to interwork with the pump assembly (10), supplied with the drug by up-down pressing, configured to form holes in the skin using a plurality of needle disks (21) so that the drug penetrates into the skin, and having a drug base (16) that prevents the drug supplied from the pump assembly (10) from flowing down, and accumulates a predetermined amount of the drug inside an arcuate bottom (28) so that the drug is appropriately supplied to the needle disks 21 when the needle disks 21 are rotated.

Abstract: An object of the present invention is to provide a method of producing a microneedle array that enables concentration of a drug at needle tips of the microneedle array. According to the present invention, provided is a method of producing a microneedle array, including a step of filling a hydrophobic mold with a drug-containing solution to form a needle tip, and a step of filling the mold including the formed needle tip with a liquid which contains a water-soluble polymer or disaccharides to form a needle base and a sheet, in which the drug-containing solution contains 0.01 mg/mL to 5 mg/mL of a surfactant.

Abstract: A power supply unit for a tattoo machine includes a power operating unit electrically connected to a power supply device. The power operating unit is electrically connected to an operating unit. The power operating unit can output a DC power and can control a current value or a voltage value of the DC current according to operation of the operating unit. A modulating unit is electrically connected to the power operating unit and the operating unit. The modulating unit modulates the DC current according to the operation of the operating unit and outputs a square wave power or the DC power. The modulating unit can control frequency or a work cycle of the square wave power according to the operation of the operating unit. An output end of the DC power supply unit is electrically connected to the tattoo machine to output the square wave power or the DC power.

Abstract: The present invention relates to a flushing catheter device, flushing catheter components, and methods for making the same. A flushing catheter includes one or more flush segments comprised of one or more flush ports along a length of catheter body. A preferred method for making a flushing catheter incorporates a retrofit including one or more flush segments. Flushing catheters may be nested within each other's lumens to form a multi-catheter system. Flush segments may enable radial fluid communication between the many lumens and annular lumens of a multi-catheter system, e.g. intraluminal fluid communication. A multi-catheter system including flushing catheters may be entirely purged of air with a single step of fluid injection. A flushing catheter may include a tapered distal end to further enhance the ease of procedure with a multi-catheter system.

Abstract: A therapeutic delivery device that provides a controlled release of high doses of a therapeutic agent in a local area, sustains the high dose controlled release with a percutaneous port for refilling the device, and is versatile for use with multiple types of therapeutic agents and/or implant systems. A rate determining/controlled release membrane is used to decrease the molecular mobility of the therapeutic compounds thereby controlling the therapeutic release profile. The therapeutic delivery device includes a body defining an internal reservoir for receiving a therapeutic agent and including a first membrane for providing a controlled release of the therapeutic agent to the surgical site, a port in fluid communication with the reservoir, a sleeve configured to encapsulate the body, and a rigid housing configured to support the body and a portion of the sleeve, the rigid housing configured to release the body and the sleeve after the body and the sleeve are anchored position relative to the surgical site.

Abstract: A therapeutic delivery device that provides a controlled release of high doses of a therapeutic agent in a local area, sustains the high dose controlled release with a percutaneous port for refilling the device, and is versatile for use with multiple types of therapeutic agents and/or implant systems. A rate determining/controlled release membrane is used to decrease the molecular mobility of the therapeutic compounds thereby controlling the therapeutic release profile. The therapeutic delivery device includes a body defining an internal reservoir for receiving a therapeutic agent and including a first membrane for providing a controlled release of the therapeutic agent to the surgical site, a port in fluid communication with the reservoir, a sleeve configured to encapsulate the body, and a rigid housing configured to support the body and a portion of the sleeve, the rigid housing configured to release the body and the sleeve after the body and the sleeve are anchored position relative to the surgical site.

Abstract: Apparatus for delivering therapeutic agents to the central nervous system of a subject is described. The apparatus includes at least one intracranial catheter and a percutaneous access device. The percutaneous access device includes a body having at least one extracorporeal surface and at least one subcutaneous surface, the body defining at least one port for connection to an implanted intracranial catheter. The port is accessible from the extracorporeal surface of the device, but is provided with a seal such as a rubber bung between the lumen of the port and the extracorporeal surface. The percutaneous access device may have more than two ports and/or a flange. A method of implanting the percutaneous access device is also described.

Abstract: The disclosure is directed to a system for maintaining hemostasis during introducing or withdrawing an interventional device. The system includes a housing. The housing includes a first end, a second end and a side wall defining a housing chamber. The system also includes a first funnel-shaped member disposed at least partially within the housing chamber. The first funnel-shaped member includes an inner portion, a middle portion and an outer portion. The inner portion of the first funnel-shaped member includes an elastic orifice, which is aligned with the through channel of the housing. The first funnel-shaped member includes an open configuration and a closed configuration. When the first funnel-shaped member is in the closed configuration, the elastic orifice is substantially closed, and when the first funnel-shaped member is in the open configuration, an interventional device is introduced through the system and the elastic orifice is open.

Abstract: A device to couple a vascular access device to a medical device may include a body, a spring, and a housing. The body may include a distal end, a proximal end, and a lumen extending through the distal end and the proximal end. The proximal end of the body may include a connector. The housing may be coupled to a proximal end of the spring and may enclose the connector. A distal end of the spring may be coupled to the body. The housing may include a flap, which may include an antimicrobial compound. When the housing is disposed in a proximal position, the flap may cover the connector, the antimicrobial compound may contact the connector, and the spring may be uncompressed. In response to movement of the housing from the proximal position to a distal position, the spring may be compressed and the flap may open.

Abstract: A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.

Abstract: A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.

Abstract: A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.

Abstract: A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.

Abstract: A medical device system for delivering a neuromodulation therapy includes a delivery tool for deploying an implantable medical device at a neuromodulation therapy site. The implantable medical device includes a housing, an electronic circuit within the housing, and an electrical lead comprising a lead body extending between a proximal end coupled to the housing and a distal end extending away from the housing and at least one electrode carried by the lead body. The delivery tool includes a first cavity for receiving the housing and a second cavity for receiving the lead. The first cavity and the second cavity are in direct communication for receiving and deploying the housing and the lead coupled to the housing concomitantly as a single unit.

Abstract: Conductors within an implantable medical lead that carry stimulation signal signals are at least partially embedded within a lead body of the medical lead over at least a portion of the length of the conductors while being surrounded by a radio frequency (RF) shield. A space between the shield and the conductors is filled by the presence of the lead body material such that body fluids that infiltrate the lead over time cannot pool in the space between the shield and the conductors. The dielectric properties of the lead body are retained and the capacitive coupling between the shield and the conductors continues to be inhibited such that current induced on the shield is inhibited from being channeled onto the conductors. Heating at the electrodes of the medical lead is prevented from becoming excessive.

Abstract: Intraoral appliances are disclosed that provide electrical stimulation to tissue in a patient's oral cavity in a manner that reduces apnea events during sleep. A representative appliance can induce a current or currents through tissue and/or anatomical structures in a manner that maintains upper airway tone and/or patency.

Abstract: A stimulation lead includes light emitters disposed along the distal portion of the lead and stimulation electrodes disposed along the distal portion of the lead with a portion of the lead upon which at least one of the light emitters and at least one of the electrodes is disposed is arranged to form a coil or spiral. Another stimulation lead includes a lead body; a paddle or cuff attached to the lead body; light emitters disposed on the paddle or cuff; and stimulation electrodes disposed on the paddle or cuff. Yet another stimulation lead includes a lead body; a paddle or cuff attached to the lead body; at least one long electrode disposed on the paddle or cuff and extending at least 50% of a width or length of the paddle or cuff; and segmented stimulation electrodes disposed in at least one row or column on the paddle or cuff.

Abstract: An electrical stimulation system includes at least one electrical stimulation lead, each of the at least one electrical stimulation lead including a plurality of stimulation electrodes; and a processor coupled to the lead and configured to perform actions, including: directing delivery of at least one electrical pulse through at least one of the stimulation electrodes of the at least one electrical stimulation lead to tissue of a patient; and directing discrete or intermittent measurement of an electrical characteristic of the tissue using at least one of the stimulation electrodes of the at least one electrical stimulation lead during, and after, delivery of the at least one electrical pulse to the tissue of the patient.

Abstract: A system and method for anchoring an electrode that stimulates a dorsal root ganglion. The anchoring device includes a screw, collet, and locking cap. The screw is inserted into bone of the pars interarticularis and the electrode is inserted through the screw and positioned next to the dorsal root ganglion for stimulation. The screw includes a recess that is shaped to fit the collet. The collet has flexible arms. When assembled, the locking cap forces the collet into the recess thereby moving the flexible arms inward radially, impinging on the electrode and holding the electrode in place adjacent the dorsal root ganglion.

Abstract: Systems, methods, and devices to facilitate insertion of certain leads with electrode(s) into patients are described. Leads can be implanted to work in conjunction with a cardiac pacemaker or cardiac defibrillator. A lead for cardiac therapy may be inserted into an intercostal space associated with the cardiac notch of a patient. Devices for delivery may include, for example, a delivery system coupled with an electrical lead and having a handle, a component advancer and insertion tips. The handle is configured to be actuated by an operator and the component advancer is configured to advance an electrical lead into the patient. The insertion tips can be configured to close around the electrical lead within the component advancer, to push through biological tissue, and to open to enable the lead to advance into the patient. The electrical lead can also be maintained in a particular orientation during the advancement into the patient.

Abstract: A method of treatment for an overactive bladder of a user includes affixing a patch externally on a dermis of the user, the patch including a flexible substrate including adhesive on a first side adapted to adhere to the dermis of the user, an electronic package directly coupled to the substrate, the electronic package including a control unit and one or more stimulators, and electrodes directly coupled to the substrate and the electronic package. The method includes detecting an urge of the user to urinate and activating the patch within approximately 10-15 seconds of the detecting, the activating including generating an electrical stimuli via the electrodes.

Abstract: An electrical-stimulation device includes an electrical-stimulation signal-generating circuit, a first connection unit, a first conductive member and a second conductive member. The electrical-stimulation signal-generating circuit has a first channel for providing a first electrical-stimulation signal. The first connection unit has a plurality of first contact points and a plurality of second contact points, wherein the first contact points and the second contact points are alternately arranged. The first conductive member is connected to the first contact points. The second conductive member is connected to the second contact points. The first conductive member and the second conductive member are electrically connected to the first channel, so that the first electrical-stimulation signal is transmitted through the first contact points and the second contact points corresponding to the first channel.

Abstract: A cochlear implant system comprising an external component having an external speech processor unit, and an internal component. The speech processor unit monitors one or more parameters, and the speech processor unit is configured to reduce the power consumption of the cochlear implant system in the absence of one or more parameters.

Abstract: A method, including applying at first and second temporal locations respective electrical currents to an electrode located in a cochlea of a recipient, obtaining first and second data indicative of electrical properties at a plurality of locations away from the electrode, the first and second data corresponding to data obtained, respectively, at the first and second temporal locations, evaluating whether or not there is an existence of a temporal change in electrical conductivity between the electrode and the plurality of locations based on the obtained data, and determining whether or not a phenomenon exists inside the cochlea based on the evaluation.

Abstract: A balloon type retinal stimulation device includes: a substrate unit having an insertion portion provided to be inserted into an eyeball; and a stimulation unit that is provided at one or both of one and the other surfaces of the substrate unit. The insertion portion is provided to be expandable and contractible as a fluid is injected into and discharged from an inside of the injection portion. When the insertion portion expands, one surface of the insertion portion is deformed to match a shape of the retina such that the stimulation unit is brought into close contact with the retina on which an image is formed, and the other surface of the insertion portion comes into close contact with an inner surface of the eyeball that is not a region of retina on which an image is formed, to support the insertion portion that is in contact with the region of retina on which an image is formed.

Abstract: A system for monitoring patient intake includes an acquisition and transmission device having an electrode configured to detect vagus nerve activity. A first internal inductive coil is configured to communicate a signal indicative of the vagus nerve activity detected by the electrode to a second external inductive coil. The system also includes a processor configured to execute instructions stored in a memory that cause the system to process the signal received by the second induction coil into data corresponding to intake of the patient and communicate the data to a server that is accessible by a clinician.

Abstract: Systems and methods for optimizing neuromodulation field design for pain therapy are discussed. An exemplary neuromodulation system includes an electrostimulator to stimulate target tissue to induce paresthesia, a data receiver to receive pain data including pain sites experiencing pain, and to receive patient feedback on the induced paresthesia including paresthesia sites experiencing paresthesia. The neuromodulation system includes a processor circuit configured to generate a spatial correspondence indication between the pain sites and the paresthesia sites over one or more dermatomes, determine an anodic weight and a cathodic weight for each of multiple electrode locations using the spatial correspondence indication, and generate a stimulation field definition for neuromodulation pain therapy.

Abstract: Provided herein are, inter alia, methods for detecting the anatomic structure of a nucleus accumbens in the brain of a subject. The method includes inserting an electrode into the ventral striatum of a subject; and detecting an oscillatory frequency of 30-40 Hz, thereby identifying the anatomic structure of a nucleus accumbens in the subject. The methods provided herein may include a step of delivering an electrical stimulation to ameliorate or prevent an OCD symptom from occurring.

Abstract: Devices and methods can be used for artificial cardiac pacing and/or resynchronization. For example, this document provides improved electrodes for stimulating and sensing electrical activity of the heart, and provides pacing and resynchronization systems incorporating such electrodes. While the devices and methods provided herein are described primarily in the context of pacing, it should be understood that resynchronization can additionally or alternatively be performed in an analogous manner, and that the scope of this disclosure includes such subject matter.

Abstract: An integrated circuit includes: a radio-frequency (RF) to direct current (DC) rectifying circuit coupled to one or more antenna on an implantable wirelessly powered device, the rectifying circuit configured to: rectify an input RF signal received at the one or more antennas and from an external controller through electric radiative coupling; and extract DC electric power and configuration data from the input RF signal; a logic control circuit connected to the rectifying circuit and a driving circuit, the logic control circuit configured to: generate a current for the driving circuit solely using the extracted DC electrical power; in accordance with the extracted configuration data, set polarity state information for each electrode; and a driving circuit coupled to one or more electrode, the driving circuit comprising current mirrors and being configured to: steer, to each electrode and via the current mirrors, a stimulating current solely from the generated current.

Abstract: The present disclosure describes systems and methods for recording electrical activity, such as local field potentials. The system can include a recording patch that is placed inline between an implanted neurological lead and an implantable pulse stimulator. The recording patch can include recording and amplification circuitry that detects, records, and amplifies electrical activity (also referred to as signals) from a target site. The system can be used to select over which of the lead's electrodes therapeutic stimulations are delivered.

Abstract: An electrical stimulation controlling device and an electrical stimulation system are provided. In which, the electrical stimulation controlling device includes a receiving circuit and a controller coupled to the receiving circuit. The receiving circuit is configured to receive an ictal neural signal which is a signal obtained by a detector when a neural event has been occurring. The controller is further coupled to a stimulator and configured to: determine a time point to start an electrical stimulation according to the ictal neural signal after an onset of the neural event has been determined; and generate and transmit a control signal to the stimulator for providing the electrical stimulation according to the determined time point.

Abstract: Systems and methods for stimulation of neurological tissue apply a stimulation waveform that is derived by a developed genetic algorithm (GA), which may be coupled to a computational model of extracellular stimulation of a mammalian myelinated axon. The waveform is optimized for energy efficiency.

Abstract: Some aspects relate to systems, devices, and methods of delivering rate responsive pacing therapy. The method includes monitoring activity information related to an activity level of a patient and delivering rate responsive pacing (RRP) to the patient at a pacing rate corresponding to a RRP profile. The RRP profile may be used to generate the pacing rate based on the activity information and may be adjusted based on the monitored activity information.

Abstract: Systems and methods for dynamically controlling His-bundle pacing (HBP) according to an indication of a rate-related or intermittent atrioventricular (AV) block in a subject are disclosed. An exemplary medical system includes an AV conduction monitor to detect an indication of either a presence or an absence of intermittent or rate-related AV conduction disturbance using physiologic information of the subject. In the event that an intermittent or rate-related AV conduction disturbance is present, a control circuit provides a control signal to an electrostimulation circuit to deliver HBP pulses. If there is no indication of intermittent or rate-related AV conduction disturbance, or a previously detected intermittent or rate-related AV conduction disturbance has been terminated, the control circuit withholds or discontinues delivery of the HBP pulses to promote intrinsic ventricular conduction and activation.

Abstract: A valve for use in manufacturing of implantable medical devices is insertable into a bore of the medical device during a manufacturing process. The valve is configured to remain closed while the pressure differential between an internal volume of the implantable medical device and a surrounding environment is below a particular threshold and to open when the threshold is reached, thereby allowing air or other fluids to escape from the internal volume into the surrounding environment. The valves are particularly useful during certain types of coating processes that must be performed at or near vacuum and provide an effective way to prevent ingress of coating material into the internal volume of the implantable medical device.

Abstract: A computer implemented method and device for providing dual chamber sensing with a single chamber leadless implantable medical device (LIMD) are provided. The method is under control of one or more processors in the LIMD configured with specific executable instructions. The method obtains a far field (FF) cardiac activity (CA) signals for activity in a remote chamber of a heart and compares the far field CA signals to a P-wave template to identify an event of interest associated with the remote chamber.